Time & Location:
May 5th 2012 (Saturday) 9:00-19:00
Northwestern University, Pancoe
Building, 2200 Campus Drive, Evanston, IL
Eevent Agenda:
9:00-9:30 Registration/ Poster Mounting
9:30-9:45 Welcome
Xianghui Liu, Ph.D., President, GLCACS 2012
Norman Li, Ph.D., Chairman of GLCACS Board of Directors
9:45-10:30 In Vitro Diagnostic Assay Technologies and Applications
John M. Robinson,Ph.D. Senior Director, Collaborative Research Management, Abbott
Laboratories.
10:30-11:45 Are You Ready for an Industrial JOB?
Lubo Zhou, Ph.D., Senior R&D manager of Gas Processing Development, UOP.
11:15-11:25 Break
11:25-12:30 Poster Presentation Competition
12:30-14:30 Poster Paper Competition and Ballot Casting
Lunch Break
Job Fair
14:30-14:45 Final Competition Ballot Casting
14:45-15:00 Poster Competition Award and Closing Remark
15:05-15:50 Carbon Nanotubes as Electronic Materials – Progress and Prospects
Nathan Yoder,Ph.D. Chief Technology Officer, NanoIntegris IncLaboratories.
15:50-16:35 Organic and Hybrid Materials for Printed Opto-Electronics
Antonio Facchetti, Ph.D., CTO of Polyera Corporation and Joint Professor of
Northwestern University
16:35-16:40 Closing Remark
17:30-19:30 Dinner Reception (Hongkong Buffet)
Guest Speakers:
In Vitro Diagnostic Assay Technologies and Applications - Dr. John M. Robinson
In vitro diagnostic assays are a critical part of our health care system and the information that they provide is used by physician's in patient management decisions. This discussion will provide an overview of the Abbott Diagnostics business with particular focus on molecular diagnostic technologies and future directions. Real time PCR and the Ibis technology are two important tools in infectious disease detection
and management. Sequencing technology is evolving at a rapid pace that will eventually lead to whole genome sequencing data being available for patient management. FISH and other molecular techniques are very useful in oncology and other genetic diseases, which has led to the use of these techniques in
pharmacogenomics applications where the results of these assays is used to make drug therapy decisions for the patient.
Biography
John M. Robinson, Ph.D. Joined Abbott in 1983. Currently Senior Director, New Technology Group, Abbott Diagnostics. Responsible for the management of collaborations aimed at establishing performance characteristics of new cutting edge technologies with immunoassay, molecular diagnostic and point-of-care applications. Most recently was Senior Director, Assay Research and Development, Abbott Molecular. Responsible for molecular diagnostic product development, including RealTime PCR, FISH, sequencing and genomic applications. Teams launched a number of infectious disease assays on the automated m 2000 System, and developed many innovative FISH and PCR based assays in oncology. Led collaborations with pharmaceutical companies to develop drug companion diagnostic assays. As Project Manager in the Abbott Diagnostics Division, developed reagents and assays for a
number of immunodiagnostic applications on the ADD IMx and AxSYM System platforms. Prior to joining Abbott, developed automated microbiology assays at Vitek Systems, Inc. Received his Ph.D. in Biology/Microbiology from the University of Alabama.
Are You Ready for an Industrial JOB? - Dr. Lubo Zhou
Carbon Nanotubes as Electronic Materials – Progress and Prospects - Dr. Nathan Yoder
Organic and Hybrid Materials for Printed Opto-Electronics - Dr. Antonio Facchetti
Graduate Research Presentation Contest Awardees:
Comments